Home
Institutions
Filings
Issuers
About
All
Index / Passive
Hedge Fund
VC / PE / Holdco
Long-Term Concentrated
Concentrated Active
Quant / Systematic
Diversified Active
LIXTE BIOTECHNOLOGY HLDGS IN
CUSIP: 539319111
Class: *W EXP 11/30/202
Ethos Financial Group, LLC's Holding History (CIK: 0001954242)
Note: Option positions (PUT/CALL) are excluded.
Q2 2024
Shares
42,105
Value ($000)
$0
Avg Close
—
Range
—
Q2 2023
Shares
42,105
Value ($000)
$4
Avg Close
—
Range
—
Period
Shares
Value ($000)
Average Close
Price Range
Q2 2024
42,105
$0
—
—
Q2 2023
42,105
$4
—
—